Substance-Related Disorders Flashcards

1
Q

Substance Use Disorder

A

Using large amounts or for longer time than intended
Persistent desire or unsuccessful attempts to cut down or control use
Great deal of time obtaining, using, or recovering
Craving
Fail to fulfill major roles (work, school, home)
Persistent social or interpersonal problems caused by substance use
Important social, occupational, recreational activities given up or reduced
Use in physically hazardous situations
Use despite physical or psychological problems caused by use
Tolerance
Withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which substances have no withdrawal even after repeated use?

A

PCP, inhalants, hallucinogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Severity of disorder

A

Depends on # of symptom criteria endorsed
Mild: 2-3 symptoms
Moderate: 4-5 symptoms
Severe: 6 or more symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Specifiers of substance use disorder?

A

In early remission: no criteria for > 3 months but < 12 months (except craving)
In sustained remission: no criteria for > 12 months (except craving)
In a controlled environment: access to substance restricted (e.g. jail)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Intoxication

A

REVERSIBLE substance-specific syndrome due to recent ingestion
Behavioral/psychological changes due to effects on CNS after ingestion (e.g. disturbances of perception, wakefulness, attention, thinking, judgement, psychomotor behavior and interpersonal behavior)
Not due to another medical condition or mental disorder
* Does not apply to tobacco

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Withdrawal

A

Substance-specific syndrome due to stopping or reducing prolonged use
Physiological & cognitive components
Significant distress in social, occupational or other important areas of functioning
Not due to another medical condition or mental disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Substance-Induced Mental Disorder

A

Can be due to any of the 10 classes of substances
During or within 1 month of use
Not an independent mental disorder (can’t have preceded onset of use or persist for substantial time after use)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

10 classes of substances?

A
Alcohol
Caffeine
Cannabis
Hallucinogens (e.g. PCP)
Inhalants
Opioids
Sedatives, hypnotics, anxiolytics
Stimulants
Tobacco
Other (gambling??)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Neuroadaptation

A

Underlying CNS changes that occurs after repeated use such that person develops tolerance and/or withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pharmacokinetic neuroadaptation

A

Adaptation of metabolizing system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pharmacodynamic neuroadaptation

A

Ability of CNS to function despite high blood levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tolerance

A

Need to use an increased amount of substance in order to achieve desired effect
OR
Markedly diminished effect with continued use of same amount of substance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Rates of substance abuse by age

A

1% of 12 y/o
25 % of 21 y/o
1% of 65 y/o

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Does starting substance use at earlier age matter?

A

Starting at earlier age (<15 y/o), more likely to become addicted
e.g. alcohol addiction is 18% if started use before 15 y/o vs. 4% if started at 18 y/o or older

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Demographics associated with substance abuse?

A
Men
American Indians and whites
Unemployed
Large metro areas
Parolees
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Alcohol epidemiology

A

$300 billion/year spent on alcohol
13 million require tx for alcohol
(vs. 5.5 million require tx for drug use)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What percent of population reported using Rx meds non-medically within past month?

A

2.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What percent of hospital admissions have alcohol or drugs associated?

A

40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What percent of hospital deaths have alcohol or drugs associated?

A

25% = 100,000 deaths per year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Intoxication is associated with what % of MVAs, DV cases, murders?

A

50% of all MVAs
50% of all DV cases
50% of all murders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

ER visits due to substances?

A
1.2 million = non-medical use of pharmaceuticals!!
660 K = alcohol
425 K = cocaine
380 K = marijuana
210 K = heroin
93 K = stimulants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Is substance abuse a “brain disease”?

A

Changes in structure and neurochemistry transform voluntary drug-using to compulsive using
Changes are not necessary/sufficient (drug-dependent person changes behavior in response to positive reinforcers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Psychodynamic etiology?

A

Disturbed ego function (inability to deal with reality)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Self-medication etiology?

A

Alcohol - panic
Opioids - anger
Amphetamines - depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Genetic etiology?
Well-established with alcohol
26
Conditioning etiology?
Behavior is maintained by its consequences: - Terminate aversive state (pain, anxiety, withdrawal) - Special status - Euphoria - Secondary reinforcers (e.g. paraphernalia)
27
What happens to cellular receptors with substance abuse?
Too little endogenous opioid activity (i.e. low endorphins) OR too much endogenous opioid antagonist activity = increased risk of dependence It's a normal endogenous receptor BUT long-term use modulates it = need exogenous substance to maintain homeostasis
28
Learning and physiological basis for dependence?
Using drugs or stopping use leads to depleted state resulting in dysphoria and/or cravings, reinforcing the use of more drug Brain cells respond by downregulating receptors and/or decreasing production of neurotransmitters that are in excess of normal levels
29
Comorbidity of substance use disorders with other psych disorders?
Up to 50% of addicts have comorbid psychiatric disorder (antisocial PD, depression, suicide)
30
What percent of patients are eventually able to abstain or decrease use to not meet criteria after treatment?
70%
31
When to treat in hospital?
Drug OD, risk of severe withdrawal, medical comorbidities, requires restricted access to drugs, psychiatric illness with SI
32
When to treat in residential treatment unit?
No intensive medical/psychiatric monitoring needs Require restricted environment Partial hospitalization
33
When to treat in outpatient program?
No risk of med/psych morbidity | Highly motivated patient
34
Behavioral interventions
Must target internal and external reinforcers Motivation to change (MI), group therapy, individual therapy, contingency management, self-help recovery groups (AA), therapeutic communities, aversion therapy, family involvement/therapy, twelve-step facilitation, relapse prevention
35
Alcohol intoxication
Blood alcohol level 0.08 g/dL Progresses from mood lability, impaired judgment, and poor coordination to increased level of neurologic impairment (severe dysarthria, amnesia, ataxia, obtundation)
36
How can alcohol intoxication be fatal?
Loss of airway protective reflexes Pulmonary aspiration Profound CNS depression
37
Symptoms of early alcohol withdrawal?
Anxiety, irritability, tremor Headache, insomnia, nausea Tachycardia, HTN, hyperthermia Hyperactive reflexes
38
Symptoms of late alcohol withdrawal?
``` Seizures (24-48 hours), usually grand mal Delirium tremens (48-72 hours) with altered mental status, hallucinations, marked autonomic instability, LIFE THREATENING ```
39
What is CIWA?
Clinical Institute Withdrawal Assessment for Alcohol - Score orientation, n/v, tremor, sweating, anxiety, agitation, tactile/auditory/visual disturbances, headache - Total score >10 indicates severe withdrawal
40
Inpatient treatment for alcohol withdrawal?
* Benzodiazepines - cross-tolerant with alcohol, reduce risk of seizures, provide comfort/sedation * Anticonvulsants (carbamazepine, valproate) - reduce risk of seizures and maybe kindling, good for protracted withdrawal * Thiamine supplementation - risk of thiamine deficiency (Wernicke/Korsakoff)
41
Medications used for alcohol use disorder
Disulfiram, Naltrexone, Acamprosate
42
Disulfiram (Antabuse)
250-500 mg PO daily Inhibits aldehyde dehydrogenase and dopamine beta hydroxylase Aversive reaction when alcohol ingested (vasodilatation, flushing, n/v, hypotension/HTN, coma/death) Watch out for disguised forms of alcohol (cologne, sauces, mouth wash, OTC cough meds)
43
Disulfiram side effects?
* Hepatotoxicity - check LFTs and h/o hep C * Neurologic - polyneuropathy/paresthesias that increase over time, increased risk with higher doses * Psychiatric - psychosis, depression, confusion, anxiety * Dermatologic - rashes, itching
44
Naltrexone
``` 50 mg PO daily Opioid antagonist (blocks mu receptors?) Reduces intoxication euphoria and cravings Hepatotoxicity at high doses - check LFTs ```
45
Acamprosate (Campral)
666 mg PO TID Unknown MOA Stabilizes neuron excitation and inhibition? Interacts with GABA and glutamate receptor? Cleared renally - check kidney fx
46
Benzodiazepine/barbiturate intoxication?
Similar to alcohol but less cognitive/motor impairment Variable rate of absorption (lipophilic), onset of action, and duration in CNS * More lipophilic and shorter duration of action = more "addicting"
47
Benzodiazepine withdrawal symptoms?
Similar to alcohol but time frame depends on half-life | Anxiety, irritability, tremor, sweating, insomnia, fatigue, headache, poor concentration
48
Benzodiazepine withdrawal treatment?
Convert short half-life BZD to long half-life BZD, then slowly taper (common mistake is tapering too fast, symptoms worse at end of taper) Outpatient taper: decrease dose every 1-2 weeks and not more than 5 mg diazepam dose equivalent Consider carbamazepine or valproate if doing rapid taper
49
5 mg diazepam is equal to what?
0.5 mg alprazolam = 25 mg chlordiazepoxide = 0.25 mg clonazepam = 1 mg lorazepam
50
Which BZDs are not affected by age or hepatic insufficiency?
Oxazepam, temazepam, lorazepam | Metabolized through only glucuronidation in liver
51
Which BZD is least lipophilic?
Chlordiazepoxide | Half-life 30-100 hrs
52
Which BZD is most lipophilic (more addicting)?
Diazepam | Half-life 30-100 hrs
53
Opioid MOA
Bind mu receptors in CNS to modulate pain
54
Opioid intoxication
Pinpoint pupils, sedation, constipation, hypotension, bradycardia, decreased RR
55
Opioid withdrawal
Not life threatening unless severe medical illness Extremely uncomfortable Dilated pupils, lacrimation, goosebumps, n/v, diarrhea, myalgias, arthralgias, dysphoria or agitation
56
Opioid withdrawal treatment
Symptomatically Antiemetic, antacid, antidiarrheal Muscle relaxant (methocarbamol) NSAIDs, clonidine, maybe BZD
57
Opioid neuroadaptation
Increased dopamine | Decreased NE
58
Medications used for opiate use disorder
Methadone, Naltrexone, Buprenorphine
59
Naltrexone
Opioid blocker, mu antagonist | 50 mg PO daily
60
Methadone
Mu agonist Start at 20-40 mg, titrate up to 80-100 mg daily Needs to be enrolled in a certified opiate substitution program
61
Buprenorphine
Partial mu agonist with ceiling effect Any physician can Rx after taking certified ASAM course Helpful for highly motivated people who do not need high doses
62
Acute stimulant intoxication
Psychological: euphoria, enhanced vigor, gregariousness, hyperactivity, restlessness, interpersonal sensitivity, anxiety, tension, anger, impaired judgment, paranoia Physical: tachycardia, papillary dilation, HTN, n/v, diaphoresis, chills, weight loss, chest pain, cardiac arrhythmias, confusion, seizures, coma
63
Chronic stimulant intoxication
Affective blunting, fatigue, sadness, social withdrawal, hypotension, bradycardia, muscle weakness
64
Stimulant withdrawal
Not severe but have exhaustion with sleep (crash) | Treat with rest and support
65
Cocaine use?
Nasal, IV, smoked Vasoconstrictive effects (may outlast use), increased risk for CVA and MI - get EKG Rhabdomyolysis with compartment syndrome from hypermetabolic state Psychosis associated with intoxication (resolves) No medications FDA-approved for tx of use disorder
66
Cocaine neuroadaptation
Prevents reuptake of dopamine
67
Amphetamine use?
Oral, IV, nasal, smoked Similar intoxication syndrome to cocaine but usually longer No vasoconstrictive effects Chronic use = neurotoxicity from glutamate and axonal degeneration? Permanent amphetamine psychosis with continued use No medication treatment (atypical antipsychotics?)
68
Amphetamine neuroadaptation
Inhibits reuptake of DA, NE, 5HT - greatest effect on DA
69
Most important preventable cause of death/disease in the U.S.?
Tobacco
70
How many current tobacco smokers? Ex-smokers?
25% current smokers, 25% ex-smokers
71
Percent of all U.S. deaths attributed to tobacco?
20%
72
How many smokers die of tobacco-induced disorder?
45%
73
What percent of schizophrenic patients smoke tobacco?
75-90%
74
Drug interactions with tobacco?
Induces CYP1A2 - watch for interactions with olanzapine
75
Tobacco intoxication, tolerance, withdrawal?
No intoxication diagnosis! (dizziness, headache, nausea) Rapid tolerance Withdrawal: dysphoria, irritability, anxiety, decreased concentration, insomnia, increased appetite
76
Tobacco neuroadaptation?
Nicotine ACh receptors on dopamine neurons in ventral tegmental area release dopamine in nucleus accumbens
77
Tobacco use disorder treatment?
CBT Agonist substitution therapy (nicotine gum or lozenge, transdermal patch, nasal spray) Meds: bupropion 150 mg PO BID, varenicline 1 mg PO BID
78
Hallucinogens
Naturally occurring mescaline, magic mushroom | Synthetic - LSD, DMT, STP, MDMA
79
MDMA (ecstacy) effects
Enhanced empathy, personal insight, euphoria, increased energy 3-6 hour duration
80
MDMA intoxication
Illusions, hyperacusis, sensitivity of touch/taste/smell, "oneness with the world", tearfulness, euphoria, panic, paranoia, impaired judgment
81
MDMA tolerance/dependence?
Tolerance develops quickly | Unpleasant side effects (teeth grinding) = dependence less likely
82
MDMA neuroadaptation
Affects 5HT, dopamine, NE but predominantly 5HT2 receptor agonist
83
MDMA psychosis
Hallucinations generally mild Paranoid psychosis with chronic use Serotonin neural injury associated with panic, anxiety, depression, flashback, psychosis, cognitive changes
84
MDMA withdrawal
Unclear syndrome | Maybe similar to mild stimulants - sleepiness and depression due to 5HT depletion
85
What is the most commonly used illicit drug in the U.S.?
Cannabis
86
Cannabis blood levels?
THC levels peak in 10-30 min | Lipid soluble = long-half life of 50 hours
87
Cannabis intoxication
Appetite and thirst, colors/sounds/tastes are clearer, increased confidence and euphoria, relaxation, increased libido, transient depression/anxiety/paranoia Tachycardia, dry mouth, conjunctival injection Slow reaction time/motor speed Impaired cognition, psychosis
88
Cannabis neuroadaptation
CB1, CB2 cannabinoid receptors in brain/body are coupled with G proteins and adenylate cyclase to Ca2+ channels, inhibiting Ca2+ influx Neuromodulator effect = decreased uptake of GABA and DA
89
Cannabis withdrawal
Insomnia, irritability, anxiety, poor appetite, depression, physical discomfort No pharmacological treatment
90
PCP ("Angel Dust") MOA
Anesthetic | Similar to ketamine - NMDA antagonist
91
PCP intoxication
Severe dissociative reactions (paranoid delusions, hallucinations, agitation/violence with decreased awareness of pain) Cerebellar symptoms - ataxia, dysarthria, nystagmus (vertical and horizontal)
92
Severe PCP overdose?
Mute, catatonic, muscle rigidity, HTN, hyperthermia, rhabdomyolysis, seizures, coma, death
93
PCP treatment?
Antipsychotic drugs or BZD if needed Low stimulation environment Acidify urine if severe toxicity/coma
94
PCP neuroadaptation
Opiate receptor effects | Allosteric modulator of glutamate NMDA receptor
95
PCP tolerance/withdrawal?
NO tolerance or withdrawal!